Literature DB >> 14972560

The vif gene of maedi-visna virus is essential for infectivity in vivo and in vitro.

Helga Bryndís Kristbjörnsdóttir1, Valgerdur Andrésdóttir, Vilhjálmur Svansson, Sigurbjörg Torsteinsdóttir, Sigrídur Matthíasdóttir, Olafur S Andrésson.   

Abstract

We have investigated the role of vif in maedi-visna virus (MVV), a lentivirus of sheep, by studying in vitro replication of vif-deleted MVV in several cell types, and the effects of vif deletion on in vivo infection. By measuring RT activity, we found that in comparison to wild-type MVV, growth of vif-deleted MVV was similar in fetal ovine synovial (FOS) cells, highly attenuated in sheep choroid plexus (SCP) cells, and not detectable in macrophages, natural target cells of MVV. Productive infection by vif-deleted MVV could not be demonstrated in sheep. An increased mutation frequency was observed in DNA produced by endogenous reverse transcription of viral RNA in vif-deleted virions, indicating the existence of a factor comparable in action to human APOBEC3G. These results suggest that the vif gene of MVV is essential for infectivity and that the Vif protein protects the viral genome from enpackaged mutagenic activities.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14972560     DOI: 10.1016/j.virol.2003.09.044

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  10 in total

1.  Simultaneous mutations in CA and Vif of Maedi-Visna virus cause attenuated replication in macrophages and reduced infectivity in vivo.

Authors:  Bjarki Gudmundsson; Stefán Ragnar Jónsson; Oddur Olafsson; Gudrún Agnarsdóttir; Sigrídur Matthíasdóttir; Gudmundur Georgsson; Sigurbjorg Torsteinsdóttir; Vilhjálmur Svansson; Helga Bryndís Kristbjornsdóttir; Sigrídur Rut Franzdóttir; Olafur S Andrésson; Valgerdur Andrésdóttir
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

2.  Evolution of HIV-1 isolates that use a novel Vif-independent mechanism to resist restriction by human APOBEC3G.

Authors:  Guylaine Haché; Keisuke Shindo; John S Albin; Reuben S Harris
Journal:  Curr Biol       Date:  2008-05-22       Impact factor: 10.834

3.  Vaccination of rhesus macaques with a vif-deleted simian immunodeficiency virus proviral DNA vaccine.

Authors:  Ellen E Sparger; Robert A Dubie; Barbara L Shacklett; Kelly S Cole; W L Chang; Paul A Luciw
Journal:  Virology       Date:  2008-02-07       Impact factor: 3.616

4.  Evolutionarily conserved and non-conserved retrovirus restriction activities of artiodactyl APOBEC3F proteins.

Authors:  Stefán R Jónsson; Guylaine Haché; Mark D Stenglein; Scott C Fahrenkrug; Valgerdur Andrésdóttir; Reuben S Harris
Journal:  Nucleic Acids Res       Date:  2006-10-11       Impact factor: 16.971

Review 5.  Host restriction of lentiviruses and viral countermeasures: APOBEC3 and Vif.

Authors:  Stefán R Jónsson; Valgerdur Andrésdóttir
Journal:  Viruses       Date:  2013-07-30       Impact factor: 5.048

Review 6.  Immunogenetics of small ruminant lentiviral infections.

Authors:  Nancy Stonos; Sarah K Wootton; Niel Karrow
Journal:  Viruses       Date:  2014-08-22       Impact factor: 5.048

Review 7.  Maedi-Visna virus: current perspectives.

Authors:  Esperanza Gomez-Lucia; Nuria Barquero; Ana Domenech
Journal:  Vet Med (Auckl)       Date:  2018-05-21

8.  Potential APOBEC-mediated RNA editing of the genomes of SARS-CoV-2 and other coronaviruses and its impact on their longer term evolution.

Authors:  Jeremy Ratcliff; Peter Simmonds
Journal:  Virology       Date:  2021-01-07       Impact factor: 3.616

9.  Characterization of a new 5' splice site within the caprine arthritis encephalitis virus genome: evidence for a novel auxiliary protein.

Authors:  Stephen Valas; Morgane Rolland; Cécile Perrin; Gérard Perrin; Robert Z Mamoun
Journal:  Retrovirology       Date:  2008-02-29       Impact factor: 4.602

10.  Role of cullin-elonginB-elonginC E3 complex in bovine immunodeficiency virus and maedi-visna virus Vif-mediated degradation of host A3Z2-Z3 proteins.

Authors:  Jingyao Zhang; Jiaxin Wu; Weiran Wang; Hui Wu; Bin Yu; Jiawen Wang; Mingyu Lv; Xiaodan Wang; Haihong Zhang; Wei Kong; Xianghui Yu
Journal:  Retrovirology       Date:  2014-09-12       Impact factor: 4.602

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.